, ,
Abstracts this author is a contributor to:
Estimating typical, best-case and worst-case scenarios for survival time in men starting systemic therapy for castrate-resistant prostate cancer: A systematic review of randomized trials (#19)
3:30 PM
Timothy West
Best of the best orals
Patients' and their doctors’ preferences for adjuvant sorafenib after resection of intermediate to high risk RCC: what makes it worthwhile? (#121)
5:00 PM
Shomik Sengupta
Poster walkabout